Prevalence and resistance pattern of Pseudomonas aeruginosa against various antibiotics

Pakistan Journal of Pharmaceutical Sciences

Volumn 21, Issue 3, 2008, Pages 311-315

  Khan, Jamshaid Ali ^a   Iqbal, Zafar ^a   Ur Rahman, Saeed ^b   Farzana, Kalsoom ^c   Khan, Abbas ^a  

^a UNIVERSITY OF PESHAWAR   (Pakistan)

^b Postgraduate Medical Institute   (Pakistan)

^c BAHAUDDIN ZAKARIYA UNIVERSITY   (Pakistan)

Author keywords

Antibiotics; MIC; Nosocomial infections; Prevalence; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; AZTERONAM; CEFTAZIDIME; ENOXACIN; GENTAMICIN; IMIPENEM; MEROPENEM; OFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; SPARFLOXACIN; SULTAMICILLIN; TOBRAMYCIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM ISOLATE; CONTROLLED STUDY; DISK DIFFUSION; FEMALE; GENDER; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; ORTHOPEDICS; PREVALENCE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; PUS; URINE; WARD; CROSS INFECTION; DRUG EFFECT; GRAM NEGATIVE INFECTION; GROWTH, DEVELOPMENT AND AGING; HOSPITAL; HOSPITAL PATIENT; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; PROSPECTIVE STUDY; SEASON; SUPPURATION;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DISK DIFFUSION ANTIMICROBIAL TESTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HOSPITALS; HUMANS; INPATIENTS; MALE; MICROBIAL SENSITIVITY TESTS; PREVALENCE; PROSPECTIVE STUDIES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SEASONS; SUPPURATION; URINE;

EID: 55249125061     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Agarwal R, Dheeraj Gupta and Pallab Ray (2006). Epidemiology, risk factors and outcome of nosocomial infections in a Respiratory Intensive Care Unit in North India. Journal of infection, 53(2): 98-105. (Pubitemid 44028674)
2. Ako-Nai A K, Ikem IC, Akinloye OO, Aboderin AO, Ikem RT and Kassim OO (2006). Characterization of bacterial isolates from diabetic foot infections in Ile-Ife, South western Nigeria. The Foot, 16(3): 158-164.
3. Al-Lawati AM, Crouch ND and Elhag KM (2000). Antibiotic consumption and development of resistance among Gram negative bacilli in intensive care units in Oman. Ann. Saudi Med., 20: 324-327.
4. Arshi S, Manzoor T, Syed S and Assadullah S (2007). In vitro sensitivity pattern of Pseudomonas aeruginosa strain isolated from patient skims-role of antimicrobial in the emergence of multiple resistance strains. J. K. Practitioner, 14(1): 31-34.
5. Balkhy HH, Gwen Cunningham and Fong Khew Chew (2006). Hospital- and community-acquired infections: a point prevalence and risk factors survey in a tertiary care center in Saudi Arabia. International Journal of Infectious Diseases, 10(4): 326-333.
6. Bert F, Maubec and Bruneau B (1998). Multi-resistance Pseudomonas aeruginosa out break associated with contaminated tape water in a neurosurgery intensive-care unit. Journal of Hospital Infection, 39: 53-62.
7. Carmeli Y, Troillet N, Eliopoulos GM and Samore MH (1999). Emergence of antibiotic- resistant Pseudomonas aeruginosa: comparison of risks associated with different antiseudomonal agents. Antimicrob. Agents Chemother., 43:1379-1382. (Pubitemid 29259329)
8. Dark JKG (1988). Pathogenesis and therapy of Pseudomonas aeruginosa. Eye, 2: 46-55.
9. Donnel DGO (1993). Sinusitis due to Pseudomonas aeruginosa in patients with human immunodeficiency virus infection. Clin. Infect. Dis., 16: 404-406. (Pubitemid 23066951)
10. Elhag KM, Reed M and Al-Lawaty HM (1999). The prevalence of antibiotic resistance among Gram negative bacilli from intensive care units in Oman. Saudi Medical Journal, 20: 373-377. (Pubitemid 29469965)
11. Fang G, Keys TF and Gentry LO (1993). Prosthetic value endocarditis resulting from nosocomial bacteremia. A prospective, multicenter study. Ann. Intern. Med., 119: 560-567. (Pubitemid 23311256)
12. Flores G, Stavola JJ and Noel GJ (1993). Bacteremia due to Pseudomonas aeruginosa in children with AIDS. Clin. Infect. Dis., 16: 706-708. (Pubitemid 23136571)
13. th edn. Washington DC: American Society for Microbiology, pp.429-441.
14. Govan JRW (1992). Microbiology of lung infection in cystic fibrosis. British Medical Bulletin, 48: 912-930.
15. Jennifer M Andrews (2001). Determination of minimum inhibitory concentration. Journal of Antimicrobial Chemotherapy; 48(Suppl-SI): 5-16.
16. John Smith MB, John Payne E, Thomas Berne V (2000). The surgeons Guide to antimicrobial Chemotherapy, pp.38-74.
17. Lizioli A, Privitera G and Alliata E (2003). Prevalence of nosocomial infections in Italy: result from the Lombardy survey in (2000). Journal of Hospital Infection, 54(2): 141-148. (Pubitemid 38002013)
18. Mayhall CG (1996). Nosocomial burn wound infection. Mayhall GC Ed. Hospital epidemiology and infection control. William and Wilkins Co., Baltimore, MD, USA, pp.225-236.
19. Monica Cheesbrough (1991). Medical Laboratory Manual for Tropical Countries, Volume-II. University Press Cambridge (UK), pp.286-287.
20. Murase M, Miyamoto H, Handa T, Sahaki S and Takenchi N (1995). Activities of antipseudomonal agent against clinical isolates of Pseudomonas aeruginosa. Jpn. J. Antibiot., 48(10):1581-1589.
21. th ed. Approval standard M2-A5.National Committee for Clinical Laboratory Standards. Villanova. Pa.
22. Odelola HA, Jaiyebo O, Anukamand PA and Akannia AO (1989). Comparative in vitro antibacterial activity of two brands of antibiotics against clinical isolates of some bacterial genera. Afr. J. Med. Sci., 18: 307-310. (Pubitemid 20077625)
23. Srikumar R, Li XZ and Poole K (1997). Inner membrane efflux components are responsible for β-lactam specificity of multi drug efflux pumps in Pseudomonas aeruginosa. J. Bacteriol., 179: 7875-7881. (Pubitemid 27525722)
24. Van Elder J (2003). Multicentre surveillance of Pseudomonas aeruginosa susceptibility pattern in nosocomial infection. J. Antimicrobial Chemotherapy, 51: 347-352. (Pubitemid 36231155)
25. th edn. McGraw-Hill, New York, p.123.